Category

AUTOINMMUNE DISEASES

Home > Therapeutic Areas > AUTOINMMUNE DISEASES (Page 7)

Taxonera C, Calvet X, Gisbert JP, Rodrigo L, Bujanda L, Muñoz F, Ponce M, Gómez-Camacho F, Mendoza JL, Oyagüez I, Sabater FJ, on behalf of COSCOL study investigators

 

Postcolectomy burden in ulcerative colitis patients undergoing colectomy
4th Congress of the European Crohn’s and Colitis Organization (ECCO). Hamburg, Germany. 5-7 feb 2009

Puig Ll, Sanchez-Carazo JL, Dauden E, Vanaclocha F, Toribio J, Pujol R, Casado MA, Sabater FJ

 

 

Quality of life in moderate to severe psoriasis patients in Spain
11th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Athens, Greece. 8-11 nov 2008

Taxonera C, Rodrigo L, Casellas F, Calvet X, Gómez-Camacho F, Ginard D, Castro M, Castro L, Ponce M, Martínez P, Ricart E, Gisbert JP, López-San Roman A, Morales JM, Casado MA

 

Infliximab maintenance therapy decreases the use of non-pharmacological resources in patients with Crohn´s disease
Digestive Disease Week (DDW). San Diego, CA, EEUU. 17-22 may 2008

Taxonera C, Rodrigo L, Casellas F, Calvet X, Gómez-Camacho F, Ginard D, Castro M, Castro L, Ponce M, Martínez P, Ricart E, Gisbert JP, López-San Roman A, Morales JM, Casado MA

 

Utilización de recursos sanitarios en pacientes con enfermedad de Crohn´, luminal y fistulizante, tratados con infliximab en condiciones de práctica clínica
XI Reunión de la Asociación Española de Gastroenterología (AEG). Madrid, España. 6-8 mar 2008

Taxonera C, Rodrigo L, Casellas F, Calvet X, Gómez-Camacho F, Ginard D, Castro M, Castro L, Ponce M, Martínez P, Ricart E, Gisbert JP, López-San Roman A, Morales JM, Casado MA

 

Infliximab impact on the use of health care resources among patients with Crohn´s disease in clinical practice conditions
3rd Congress of the European Crohn´s and Colitis Organization (ECCO). Lyon, France. 28 feb-1 mar 2008

Saro C, de la Coba C, Casado MA, Morales JM, Otero B

 

 

La terapia con infliximab se asocia con un ahorro de costes en la atención sanitaria del paciente con enfermedad de Crohn
X Reunión de la Asociación Española de Gastroenterología (AEG). Madrid, España. 29-30 mar 2007

Blasco P, Calvo J, Bernalte A, Moreno J, Gómez JD, Casado MA

 

 

Influence of vial optimisation and use of day-care facilities on the costs of infliximab administration
12th Congress of the European Association of Hospital Pharmacists (EAHP). Bourdeaux, France. 21-23 mar 2007

De la Morena LV, Sanz J, De la Morena C, Folguera J, Casado MA

 

 

Economic impact of infliximab based on the diagnosis of patients treated in the Rheumatology service
12th Congress of the European Association of Hospital Pharmacists (EAHP). Bourdeaux, France. 21-23 mar 2007

Saro C, de la Coba C, Casado MA, Morales JM, Otero B

 

 

Infliximab is associated with decreased healthcare costs in patients with Crohn´s disease. Inflammatory Bowel Diseases
2nd Congress of the European Crohn´s and Colitis Organization (ECCO). Innsbruck, Austria. 1-3 mar 2007